; and (ii) one co-chair shall be designated by the Secretary from among voting members appointed under subparagraph (E), (F), or (G) of paragraph (1). (B) Rotation of non-government co-chair The Secretary shall rotate designations of co-chairs under subparagraph (A)(ii) from among voting members appointed under subparagraph (E), (F), or (G) of paragraph (1). (C) Term of service for non-government co-chair Each co-chair designated under subparagraph (A)(ii) shall serve a term of 2 years. (3) Compensation (A) In general Except as provided in subparagraph (B), members of the Task Force shall serve without compensation. (B) Travel expenses A member of the Task Force may be allowed travel expenses, including per diem in lieu of subsistence, at rates authorized for an employee of an agency under subchapter I of chapter 57 of title 5, United States Code, while away from the home or regular place of business of the member in the performance of the duties of the Task Force. (d) Meetings The Secretary shall convene the Task Force not less frequently than 4 times each year. The Secretary shall convene the first meeting of the Task Force no later than July 1, 2020. (e) Duties The Task Force shall carry out the following duties: (1) Identification of innovative diabetes technologies and services The Task Force shall— (A) identify innovative diabetes technologies and services for the treatment of type I diabetes, type II diabetes, or both, that are in development or that have been cleared or approved by FDA and that are wholly or partially inaccessible to Medicare beneficiaries with diabetes under Medicare; (B) develop and consider possible alternative approaches to enable Medicare beneficiaries to access innovative diabetes technologies and services